Eco‐Friendly Simultaneous Quantification of Domperidone and Safinamide by Spectral Resolution using deconvoluted Synchronous Fluorescence: Application to Spiked Human Plasma
- 28 August 2025
- journal article
- Published by Wiley in Luminescence
- Vol. 40 (9) , e70294
Abstract
A novel, eco‐friendly deconvoluted synchronous spectrofluorimetric method has been developed and validated for the simultaneous determination of domperidone (DOM) and safinamide (SAF), a potential combination used to address Parkinson's disease–associated gastrointestinal dysfunction. Their combined administration necessitates a reliable analytical method for therapeutic monitoring and formulation quality control. Traditional spectrofluorimetric techniques fail to resolve the significant spectral overlap between these two compounds. In this study, a deconvoluted synchronous spectrofluorimetric method, using Fourier self‐deconvolution at Δλ = 30 nm, successfully resolved the overlapping fluorescence spectra without any need for physical separation. It showed excellent linearity (DOM: 10–1500 ng/mL, SAF: 50–2000 ng/mL), with low LOD (2.75 ng/mL for DOM and 11.77 ng/mL for SAF), high recovery rates in both pharmaceutical forms and spiked human plasma (above 90%), and outstanding selectivity and robustness. Sustainability of the current method was assessed using spider chart measure, green solvent selection tool, Analytical GREEnness Metric, Modified Green Analytical Procedure index, and Blue Applicability Grade Index. The proposed technique represents a simple, sensitive, and sustainable tool for routine analysis of this therapeutically significant drug pair.Keywords
This publication has 37 references indexed in Scilit:
- Spider diagram with greenness assessment criteria for mathematical UV spectrophotometric methodologies for separating overlaid spectrum signals of diclofenac sodium and lidocaine hydrochlorideGreen Analytical Chemistry, 2025
- Pharmacokinetic and Safety Study of Single and Multiple Oral Doses of Safinamide in Healthy Chinese VolunteersClinical Pharmacology in Drug Development, 2023
- Green micelle and complex inclusion enhance synchronous spectrofluorimetric quantification of a novel analgesic combination: Tramadol and celecoxib in tablet dosage form and spiked human plasmaLuminescence, 2023
- HPLC-Fluorescence Detection Method for Concurrent Estimation of Domperidone and Naproxen. Validation and Eco-Friendliness Appraisal StudiesJournal of Fluorescence, 2022
- Contemporary Options for the Management of Motor Complications in Parkinson’s Disease: Updated Clinical ReviewDrugs, 2019
- Fourth‐derivative synchronous spectrofluorimetry and HPLC with fluorescence detection as two analytical techniques for the simultaneous determination of itopride and domperidoneLuminescence, 2015
- Randomized trial of safinamide add‐on to levodopa in Parkinson's disease with motor fluctuationsMovement Disorders, 2013
- Second-derivative Synchronous Fluorometric Method for the Simultaneous Determination of Cinnarizine and Domperidone in Pharmaceutical Preparations. Application to Biological FluidsJournal of Fluorescence, 2007
- An improved HPLC assay with fluorescence detection for the determination of domperidone and three major metabolites for application to in vitro drug metabolism studiesJournal of Chromatography B, 2007
- Pharmacokinetics and Dose Proportionality of Domperidone in Healthy VolunteersThe Journal of Clinical Pharmacology, 1986